학술논문

Variants in SCAF4 Cause a Neurodevelopmental Disorder and Are Associated with Impaired mRNA Processing
Document Type
article
Source
American Journal of Human Genetics. 107(3)
Subject
Biological Sciences
Bioinformatics and Computational Biology
Genetics
Brain Disorders
Clinical Research
Intellectual and Developmental Disabilities (IDD)
Human Genome
Neurosciences
2.1 Biological and endogenous factors
Aetiology
Animals
Child
Drosophila melanogaster
Female
Gene Knockdown Techniques
Genetic Variation
Heterozygote
Humans
Intellectual Disability
Locomotion
Male
Mutation
Neurodevelopmental Disorders
RNA Polymerase II
RNA Processing
Post-Transcriptional
RNA
Messenger
Seizures
Serine-Arginine Splicing Factors
Exome Sequencing
UCLA Clinical Genomics Center
SCAF4
epilepsy
intellectual disability
mRNA processing
neurodevelopmental disorder
seizures
Medical and Health Sciences
Genetics & Heredity
Biological sciences
Biomedical and clinical sciences
Health sciences
Language
Abstract
RNA polymerase II interacts with various other complexes and factors to ensure correct initiation, elongation, and termination of mRNA transcription. One of these proteins is SR-related CTD-associated factor 4 (SCAF4), which is important for correct usage of polyA sites for mRNA termination. Using exome sequencing and international matchmaking, we identified nine likely pathogenic germline variants in SCAF4 including two splice-site and seven truncating variants, all residing in the N-terminal two thirds of the protein. Eight of these variants occurred de novo, and one was inherited. Affected individuals demonstrated a variable neurodevelopmental disorder characterized by mild intellectual disability, seizures, behavioral abnormalities, and various skeletal and structural anomalies. Paired-end RNA sequencing on blood lymphocytes of SCAF4-deficient individuals revealed a broad deregulation of more than 9,000 genes and significant differential splicing of more than 2,900 genes, indicating an important role of SCAF4 in mRNA processing. Knockdown of the SCAF4 ortholog CG4266 in the model organism Drosophila melanogaster resulted in impaired locomotor function, learning, and short-term memory. Furthermore, we observed an increased number of active zones in larval neuromuscular junctions, representing large glutamatergic synapses. These observations indicate a role of CG4266 in nervous system development and function and support the implication of SCAF4 in neurodevelopmental phenotypes. In summary, our data show that heterozygous, likely gene-disrupting variants in SCAF4 are causative for a variable neurodevelopmental disorder associated with impaired mRNA processing.